We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Laser Incubator Developed for Rapid Blood Group Typing

By LabMedica International staff writers
Posted on 01 Oct 2019
Blood transfusion is a critical treatment for a variety of hematological conditions, including cancer chemotherapy, sickle cell disease treatments, bleeding trauma, including childbirth, and major surgery.

Over 21 million blood components are transfused in the USA alone every year; each having the potential for fatal hemolytic transfusion reactions if recipient and donor are not accurately matched. More...
Identification of antigens and antibodies often requires incubation at human body temperature of 37 °C. Depending on the method, this incubation step can take 5 to 30 minutes.

Chemical Engineers at Monash University (Clayton, Australia) and their colleagues at Haemokinesis (Hallam, Australia) developed rapid optical heating via laser, where targeted illumination of a blood-antibody sample in a diagnostic gel card is converted into heat, via photothermal absorption. The laser-incubator heats the 75 µL blood-antibody sample to 37 °C in less than 30 seconds.

Whole blood samples were stored by refrigeration at 4 °C with ethylenediaminetetraacetic acid (EDTA) as anticoagulant and were used within two weeks post-collection. Reagent red blood cell solutions (Haemokinesis: Stargel10 3 cell screen,) were used for all RBC-antibody incubation tests. Immunoglobulin-G (IgG) anti-D antibody was used for all antibody tests except for the sensitivity control test. The RBC-antibody mixtures were prepared directly in the gel card wells (Haemokinesis Stargel10 AHG System). The gel card heating block (Prototype #5, Haemokinesis) has a fixed temperature of 37 °C. Temperature was detected during incubation directly inside the sample volume in a gel card well using a thermocouple probe.

The team showed that red blood cells act as photothermal agents under near-infrared laser incubation, triggering rapid antigen-antibody binding. They detected no significant damage to the cells or antibodies for laser incubations of up to fifteen minutes. They demonstrate laser-incubated immunohaematological testing to be both faster and more sensitive than current best practice, with clearly positive results seen from laser incubations of just 40 seconds.

Clare A. Manderson, PhD, the first author of the study, said, “Giving blood transfusions to people isn't as simple as giving O-negative to anybody. The 'universal donor' of O-negative blood can seriously harm a lot of people, even kill them. The world of pre-transfusion of blood group typing is huge, and it's really important that it's done quickly and accurately to help save lives.” The study was originally published online on August 2, 2019, in the journal Scientific Reports.

Related Links:
Monash University
Haemokinesis


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.